Cargando…
A Scale to Assess Activities of Daily Living in Pantothenate Kinase‐Associated Neurodegeneration
OBJECTIVE: Pantothenate kinase‐associated neurodegeneration (PKAN) is an autosomal‐recessive, neurodegenerative disorder with a mixed‐motor phenotype caused by a defective PanK2 enzyme, for which there are few adequate treatment options. Clinimetrically sound measures of patient‐reported outcomes ar...
Autores principales: | Marshall, Randall D., Collins, Abigail, Escolar, Maria L., Jinnah, H.A., Klopstock, Thomas, Kruer, Michael C., Videnovic, Aleksandar, Robichaux‐Viehoever, Amy, Swett, Laura, Revicki, Dennis A., Bender, Randall H., Lenderking, William R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384181/ https://www.ncbi.nlm.nih.gov/pubmed/30838313 http://dx.doi.org/10.1002/mdc3.12716 |
Ejemplares similares
-
Diagnostic and clinical experience of patients with pantothenate kinase-associated neurodegeneration
por: Marshall, Randall D., et al.
Publicado: (2019) -
The FOsmetpantotenate Replacement Therapy (FORT) randomized,
double-blind, Placebo-controlled pivotal trial: Study design and development
methodology of a novel primary efficacy outcome in patients with pantothenate
kinase-associated neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2019) -
Fosmetpantotenate Randomized Controlled Trial in Pantothenate Kinase–Associated Neurodegeneration
por: Klopstock, Thomas, et al.
Publicado: (2020) -
Pantothenate kinase-associated neurodegeneration
por: Hundallah, Khalid, et al.
Publicado: (2017) -
Study design challenges and strategies in clinical trials for rare diseases: Lessons learned from pantothenate kinase-associated neurodegeneration
por: Videnovic, Aleksandar, et al.
Publicado: (2023)